Latest Breaking News On - Glasgow royal - Page 6 : vimarsana.com
-- VAZKEPA® (icosapent ethyl) accepted by the Scottish Medicines Consortium (SMC) for restricted use within NHSScotland, as secondary prevention in adult statin-treated patients at high cardiovascular risk1 -- -- VAZKEPA® already commercially available in England, Wales, and Northern Ireland where NICE recommended its reimbursement and use across the National Health Service (NHS) in July 2022 -- -- Amarin now working with Health Boards across Scotland to secure formulary inclusion and ensure eli
United-kingdomDublinIrelandSwitzerlandUnited-statesGlasgowGlasgow-cityNorthern-irelandCraigavonNew-jerseyScotlandBritish